Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

SARS-CoV-2 has been evolving the ability to evade the immune system about twice as fast as the fastest-evolving flu virus. It averages more than a dozen significant changes every year.

Five years after the World Health Organization declared a global pandemic, there has been progress — and backsliding in the ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

DVGs (Defective Viral Genomes) are prevalent in RNA virus infections. In this investigation, we conducted an analysis of high-throughput sequencing data and observed widespread presence of DVGs in ...

SARS-CoV-2 secondary structure shapes mutation frequencies, constraining viral evolution models predicting fitness can benefit from integrating secondary structure data.

Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Third Milestone, Faridabad − Gurugram Expressway, Faridabad, Haryana 121001, India ...

Scientists found that the new virus can bind to human ACE2, making it similar to SARS-CoV-2 and NL63 (a common cold virus). The new virus called HKU5-CoV-2, discovered in bats in China ...